Tender detail
Medicinal products – non-exclusive rebate agreement for products containing erythropoietin
Summary
The tender concerns the award of a non-exclusive rebate agreement for medicinal products containing erythropoietin, specifically epoetin alfa and zeta, for the period 01/07/2026–30/06/2028. Bidders should note that DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible, and the exact compliance and qualification requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.